UMN Pharma inks flu vaccine production JV in Japan
17 February 2010
Ian Haydock
Please Login to read the full article.
17 February 2010
Ian Haydock
ian.haydock@informa.com
The Japanese bioventure UMN Pharma has entered into a domestic joint venture agreement to set up what it says will be the country's first facility for the production of cell-cultured flu vaccines.
The as yet unnamed venture will be located in Akita city, Akita prefecture, and formally incorporated...
Please Login to read the full article.
RELATED CONTENT
NEWS
- VaxInnate strikes major Asian licensing deal for novel vaccine technology
- Astellas locks in global rights to Vical's CMV vaccine for transplant use
- South Korea grants first approval worldwide to a stem cell therapy
- TVAX Biomedical plans killer $40M IPO to fund PhIII vaccine for naive astrocytoma
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
